FDA Approved Products
553 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
GYNOREST
dydrogesterone
Pre-Launch
ORAL · TABLET
NDA
HALDOL SOLUTAB
haloperidol
Pre-Launch
Johnson & Johnson
ORAL · TABLET
NDA
HALOG
halcinonide
Pre-Launch
Bristol Myers Squibb
TOPICAL · OINTMENT
NDA
HALOPERIDOL
haloperidol
Pre-Launch
Sagent Pharmaceuticals
INJECTION · INJECTABLE
NDA
HEAD & SHOULDERS CONDITIONER
pyrithione zinc
Pre-Launch
AbbVie
TOPICAL · LOTION
NDA
HEAVY SOLUTION NUPERCAINE
dibucaine hydrochloride
Pre-Launch
Novartis
INJECTION · INJECTABLE
NDA
HEDULIN
phenindione
Pre-Launch
Sanofi
ORAL · TABLET
NDA
HELIUM, USP
helium
Pre-Launch
INHALATION · GAS
NDA
HEPARIN LOCK FLUSH
heparin sodium
Pre-Launch
Pfizer
INJECTION · INJECTABLE
NDA
HEPARIN SODIUM
heparin sodium
Pre-Launch
Pfizer
INJECTION · INJECTABLE
NDA
HEPARIN SODIUM
heparin sodium
Pre-Launch
Entera Bio
INJECTION · INJECTABLE
NDA
HEPARIN SODIUM
heparin sodium
Pre-Launch
Bristol Myers Squibb
INJECTION · INJECTABLE
NDA
HEPARIN SODIUM
heparin sodium
Pre-Launch
INJECTION · INJECTABLE
NDA
HEPARIN SODIUM 1,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
heparin sodium
Pre-Launch
INJECTION · INJECTABLE
NDA
HEPARIN SODIUM 2,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
heparin sodium
Pre-Launch
INJECTION · INJECTABLE
NDA
HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
heparin sodium
Pre-Launch
INJECTION · INJECTABLE
NDA
HEXASCRUB
hexachlorophene
Pre-Launch
TOPICAL · SPONGE
NDA
HISERPIA
reserpine
Pre-Launch
ORAL · TABLET
NDA
HISPRIL
diphenylpyraline hydrochloride
Pre-Launch
GSK
ORAL · CAPSULE, EXTENDED RELEASE
NDA
HISTALOG
betazole hydrochloride
Pre-Launch
Eli Lilly and Company
INJECTION · INJECTABLE
NDA
HYDELTRASOL
prednisolone sodium phosphate
Pre-Launch
Merck & Co.
INJECTION · INJECTABLE
NDA
HYDELTRASOL
prednisolone sodium phosphate
Pre-Launch
Merck & Co.
OPHTHALMIC, OTIC · OINTMENT
NDA
HYDROCORTONE
hydrocortisone acetate
Pre-Launch
Merck & Co.
OPHTHALMIC, OTIC · OINTMENT
NDA
HYDROMOX R
quinethazone; reserpine
Pre-Launch
Pfizer
ORAL · TABLET
NDA